Passage BIO PASG Income Statement (2019-2026)

NASDAQ PASG
$4.00 +0.22 (+5.82%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Passage BIO Quarterly Income Statement

Periods 31 quarters
Latest Sep 2026

Passage BIO reported net income of -$4.72M for the quarter ended Sep 2026. This income statement covers 31 quarters of results from Mar 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Research & DevelopmentR&D
32.97M26.21M26.82M15.36M17.66M16.84M17.32M15.10M12.16M11.54M10.43M8.66M9.56M7.74M5.81M4.31M5.42M4.09M3.34M1.50M
Share-based Compensation (IS)Stock Comp.
0.82M0.73M0.54M0.45M0.24M0.25M0.17M0.18M0.14M0.05M0.00M
Selling, General & AdministrativeSG&A
17.19M15.10M12.99M10.66M10.59M19.05M8.06M8.18M6.29M6.52M6.51M7.25M4.71M6.09M4.52M4.35M4.92M4.79M6.87M3.44M
Other Operating ExpensesOther Opex
0.00M0.27M0.83M1.55M1.53M1.56M36.94M6.52M6.51M7.25M4.71M6.09M4.52M4.35M4.92M0.63M1.94M3.44M
Operating ExpensesOpex
50.16M41.31M39.81M26.03M28.24M35.88M25.39M23.28M18.45M18.05M16.94M15.91M14.27M13.82M10.33M8.66M10.34M8.88M10.22M4.94M
Operating IncomeOp. Inc
-51.16M-42.81M-39.81M-27.53M-28.24M-35.88M-25.39M-28.67M-18.45M-18.05M-17.38M-20.70M-14.27M-16.46M-10.33M-8.66M-13.85M-8.25M-8.27M-4.94M
Non-operating items
Non Operating Interest Expenses
6.61M6.07M4.49M5.52M3.79M4.15M2.88M3.70M2.43M1.46M1.33M
Goodwill impairment chargesGoodwill Impair.
5.39M0.44M4.80M2.64M3.51M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
-0.45M-0.92M-0.24M0.11M0.50M0.54M0.09M0.15M0.15M-0.03M0.00M0.10M-0.02M-0.01M
Interest & Investment IncomeInt & Inv Inc
0.01M0.00M0.27M0.83M1.17M
Other Non Operating IncomeOther Non Op Inc.
0.00M0.27M0.83M1.20M1.55M1.53M1.60M1.69M1.34M1.40M1.40M1.53M1.10M0.95M0.91M0.89M0.70M0.50M0.22M
Net income details
EBIT
-51.16M-42.81M-39.81M-27.53M-28.24M-35.88M-25.39M-28.67M-18.45M-18.05M-17.38M-20.70M-14.27M-16.46M-10.33M-8.66M-13.85M-8.25M-8.27M-4.94M
EBT
-51.15M-42.81M-39.54M-26.70M-27.07M-35.88M-25.39M-28.67M-18.45M-24.66M-23.45M-25.19M-19.79M-20.25M-14.49M-11.54M-17.55M-10.68M-9.74M-6.27M
Income After Tax
-51.15M-42.81M-39.54M-26.70M-27.07M-35.88M-25.39M-28.67M-18.45M-24.66M-23.45M-25.19M-19.79M-20.25M-14.49M-11.54M-17.55M-10.68M-9.74M-6.27M
Income from Continuing OperationsIncome (Continuing)
-51.15M-42.81M-39.54M-26.70M-27.07M-35.88M-25.39M-28.67M-18.45M-24.66M-23.45M-25.19M-19.79M-20.25M-14.49M-11.54M-17.55M-10.68M-9.74M-6.27M
Consolidated Net IncomeConsol Net Inc.
-51.60M-43.73M-39.79M-26.59M-26.57M-33.80M-23.77M-26.96M-16.61M-16.74M-15.99M-19.24M-12.75M-15.41M-9.39M-7.75M-12.98M-7.56M-7.82M-4.72M
Income towards Parent CompanyParent Net Inc
-51.15M-42.81M-39.54M-26.70M-27.07M-34.34M-23.86M-27.11M-16.76M-16.71M-15.99M-19.34M-12.73M-15.41M-9.40M-7.75M-12.98M-7.60M-7.82M-4.72M
Net Income towards Common StockholdersNet Income
-51.15M-42.81M-39.54M-26.70M-27.07M-34.34M-23.86M-27.11M-16.76M-16.71M-15.99M-19.34M-12.73M-15.41M-9.40M-7.75M-12.98M-7.60M-7.82M-4.72M
Additional items
EPS (Basic)
-19.18-15.78-14.54-9.80-9.95-12.57-8.73-9.90-6.12-5.94-5.18-6.26-4.21-4.96-2.97-2.44-4.09-2.37-2.44-1.47
EPS (Diluted)
-19.18-15.78-14.54-9.80-9.95-12.57-8.73-9.90-6.12-5.94-5.18-6.26-4.21-4.96-2.97-2.44-4.09-2.37-2.44-1.47
Shares Outstanding
2.67M2.71M2.72M2.72M2.72M2.73M2.73M2.74M2.74M2.81M3.08M3.09M3.02M3.11M3.17M3.18M3.17M3.21M3.21M3.22M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.67M2.71M2.72M2.72M2.72M2.73M2.73M2.74M2.74M2.81M3.08M3.09M3.02M3.11M3.17M3.18M3.17M3.21M3.21M3.22M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.71M2.72M2.72M2.73M2.73M2.73M2.74M2.74M2.75M3.08M3.09M3.09M3.10M3.11M3.18M3.18M3.18M3.21M3.22M3.22M
EBITDA
-49.95M-41.04M-38.64M-26.57M-27.71M-34.98M-25.16M-27.99M-18.49M-17.69M-16.88M-20.32M-13.94M-16.13M-10.13M0.00M
Interest ExpensesInt Expense
6.61M6.07M4.49M5.52M3.79M4.15M2.88M3.70M2.43M1.46M1.33M

Passage BIO Income Statement API

Pull Passage BIO's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PASG&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY